Fragile fugue: p53 in aging, cancer and IGF signaling
J Campisi - Nature Medicine, 2004 - nature.com
J Campisi
Nature Medicine, 2004•nature.comFragile fugue: p53 in aging, cancer and IGF signaling | Nature Medicine Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for CSS.
To obtain the best experience, we recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are
displaying the site without styles and JavaScript. Advertisement Nature Medicine View all
journals Search My Account Explore content About the journal Publish with us Sign up for alerts …
Thank you for visiting nature.com. You are using a browser version with limited support for CSS.
To obtain the best experience, we recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are
displaying the site without styles and JavaScript. Advertisement Nature Medicine View all
journals Search My Account Explore content About the journal Publish with us Sign up for alerts …
Aging is driven in part by an evolutionarily conserved hormone signaling pathway. A new study shows that this pathway is controlled by the p53 tumor suppressor, which exquisitely balances the need for cell proliferation against that for tumor suppression.
nature.com